Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...
Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is at a "very high" level.